Industry S Science News
This ‘glue gun ant’ fires sticky webs at its enemies
Lordomyrma azumai has repurposed its venom gland as a web slinger
Industry headlines from across biotech and life sciences, gathered from the industry press and linked straight to the publisher. Every story links straight to its publisher.
Industry S Science News
Lordomyrma azumai has repurposed its venom gland as a web slinger
Industry F FDA Law Blog
By Steven J. Gonzalez —
Industry
BioCentury
BIOCENTURY | DEALSCHINA TRENDS; ROCHE, MERCK KGAA DEALS; ARROWHEAD AND TAU — A BIOCENTURY PODCASTTrends to watch in China — from IITs to earlier deals
Industry
BioCentury
BIOCENTURY | PRODUCT DEVELOPMENTHANSOH’S WEIYONG SUN: ROCHE DEAL PART OF STRATEGY TO CAPTURE MORE UPSIDECBO Sun on dealmaking, Hansoh’s strategy, and what’s ahead for the China biopharma
Industry
BioCentury
BIOCENTURY | POLITICS, POLICY & LAWROCHE-HANSOH CO-DEVELOPMENT DEAL LANDS AMID DEBATE OVER CHINA RESTRICTIONSTreasury could release draft COINS rule, controls on outbound biotech investments, this week
Industry
Nature Biotechnology
Industry C Cell Systems
Auth et al. show that cells resolve ambiguity between opposing BMP and TGF-β cues through asymmetric crosstalk that favors TGF-β-driven responses. Mathematical modeling and experiments reveal that promiscuous SMAD heterocomplex formation redirects BMP-associated mediators toward…
Industry
Drug Discovery and Development
Roche picks the targets and Hansoh builds the ADCs under a deal with $400 million upfront, a $110 million first-anniversary payment and more than $15 billion in milestones. The split mirrors AstraZeneca’s January deal with CSPC. The post Roche picks cancer targets, Hansoh builds…
Industry
BioCentury
BIOCENTURY | DEALSROCHE ADC DEAL COULD GIVE HANSOH A PATH TO GLOBAL EXPANSION: DEALS REPORTPlus: Gilead, Vir in T cell engager agreement; Merck KGaA/Silence; and more
Industry
BioCentury
BIOCENTURY | DEALSSILENCE IS GOLDEN: GERMANY-BASED MERCK PAYS $1.3B FOR SIRNA COMPANYAugust readout in polycythemia vera was key driver of the deal
Industry
Inside Precision Medicine
From whole-genome sequencing to magnetic resonance imaging (MRI) and artificial intelligence (AI)-guided diagnostics, these five companies aim to extend healthy lives by catching illnesses before they manifest. The post The Quest for Wellness: Five Companies Preventing Disea…
Industry
MedCity News
The Silence Therapeutics acquisition gives Merck KGaA a drug ready for a pivotal test in the blood disorder polycythemia vera. Silence’s RNA therapy offers a different approach and a potential dosing advantage over a Takeda Pharmaceutical product recently approved in this indicat…
Industry
Inside Precision Medicine
Researchers uncovered how injured kidney cells recruit immune cells that worsen inflammation and demonstrated an experimental antibody strategy that reduced kidney damage in mice. The post Early Drivers of Autoimmune Kidney Damage Identified, Opening Door to Targeted Treatment ap…
Industry
Inside Precision Medicine
A new study suggests that the molecular characteristics of multiple myeloma tumors could help predict which patients achieve deep responses to four-drug therapy, offering a potential new layer of information for treatment decisions. The post Molecular Profiling May Predict Deep R…
Industry
Fierce Pharma
Monitoring the Signals: Making Remote Toxicity Management Work for Everyone jpiatt Mon, 10/19/2026 - 15:00 Wed, 12/02/2026 - 11:00 Resource Type Webinar Moderator – Lindsay Wahlstrom, MPH, CPH Jill Bell, PhD. Chad Leaver, MSc, MBA Alisha Lutat Remote patient monitoring (RPM) can…
Industry
Fierce Biotech
Monitoring the Signals: Making Remote Toxicity Management Work for Everyone jpiatt Mon, 10/19/2026 - 15:00 Wed, 12/02/2026 - 11:00 Resource Type Webinar Moderator – Lindsay Wahlstrom, MPH, CPH Jill Bell, PhD. Chad Leaver, MSc, MBA Alisha Lutat Remote patient monitoring (RPM) can…
Industry
Inside Precision Medicine
IMU Biosciences will help create a large and detailed immune dataset for 80,000 people in the UK Biobank with help from Waters Corporation and Ultima Genomics. The post IMU Biosciences and UK Biobank to Create Large Immune Dataset appeared first on Inside Precision Medicine.
Industry
GEN
IMU Biosciences and UK Biobank will profile 80,000 blood samples using technologies from Waters and Ultima Genomics, creating a high-resolution immune dataset to advance AI-driven biomedical research and disease prediction. The post Landmark UK Biobank, IMU Immune Profiling Initi…
Industry
GEN
A study in mice offers up a biological explanation for how psychological stress can contribute to arthritis flares, and identifies a stress-responsive pathway that could be explored as a potential therapeutic target. The post Psychological Stress Triggers Arthritis Flares in Mice…
Industry
STAT Biotech
A more accurate name would be “You Can See Everything That We Chose To Point The Camera At,”Theranos whistleblower Tyler Shultz writes.
Industry P Pharmaceutical Executive
Merck KGaA, Darmstadt, Germany, acquires Silence Therapeutics for $1.3 billion, Hansoh Pharma and Roche expand their ADC partnership in a deal worth over $15 billion, and an EMA panel backs Lilly’s Foundayo for obesity and type 2 diabetes in Europe.
Industry A Applied Clinical Trials
CRIO’s chief innovation officer, Mike Wenger touches on the two ways sites get AI adoption wrong.
Industry A Applied Clinical Trials
CRIO’s Mike Wenger, speaker at this year's SCRS summit, maps how sites are actually deploying AI post-pilot stage.
Industry
Inside Precision Medicine
FDA approval establishes Labcorp’s PGDx elio tissue complete CDx as a trusted companion diagnostic for advanced melanoma. The post PGDx elio<sup>®</sup> tissue complete CDx Brings Speed and Confidence to Advanced Melanoma BRAF Testing appeared first on Inside Precisio…
Industry B BioPharm International
In the phase 3 SHINE-2 trial, half of pediatric patients who responded to mirikizumab induction were in clinical remission at week 52. Lilly plans to file for a pediatric UC label expansion.
Industry
Inside Precision Medicine
A genetic variant in the CD36 gene found predominantly in people of African ancestry significantly increases the risk of the heart condition dilated cardiomyopathy in carriers. The post African Ancestry Genetic Variant Increases Risk for Cardiomyopathy appeared first on Inside Pr…
Industry P Pharmaceutical Executive
Hansoh Pharma enters a collaboration and license agreement with Roche covering a broad portfolio of antibody-drug conjugate programs.
Industry
Inside Precision Medicine
Standardize biospecimen workflows, traceability, consent management, and compliant sample sharing. The post Overcoming Biobanking Data Challenges with a Purpose-Built LIMS appeared first on Inside Precision Medicine.
Industry B BioPharm International
Guselkumab (Tremfya) sustained perianal fistula healing through 1 year in Crohn disease, with remission climbing to 35% in one FUZION dosing arm.
Industry P Practical Fragments
Targeting proteins involved in DNA repair is a promising approach against cancer. However, finding effective small molecule inhibitors can be difficult because the protein-DNA interface tends to be very polar, with few classically ligandable pockets. In a new J. Am. Chem. Soc. pa…
Industry
Clinical Trials Arena
Metastatic breast cancer trial activity remains high, but GlobalData analysis shows development is still concentrated in Phase I and II studies. The post Where options run out, BRIA-ABC bets on survival in metastatic breast cancer appeared first on Clinical Trials Arena.
Industry P PLOS Biology
by Shuji Wakatsuki, Toshiyuki Araki Neurodegeneration is frequently associated with oxidative stress, yet the mechanisms that convert reactive oxygen species (ROS) into irreversible degenerative signals remain incompletely understood. Neurons in the central and peripheral nervous…
Industry
BioPharma Dive
The acquisition gives the German company a promising blood disorder medicine that passed a Phase 2 test and could threaten a Takeda drug.
Industry
PharmaVoice
Despite an uptick in dealmaking and IPOs, a selective funding market and scientific setbacks are still pushing some biotechs to the brink.
Industry
European Biotechnology
Helping biopharmaceutical innovators build scalable, manufacturable, and commercially viable processes from the start. The post From development to commercial reality appeared first on European Biotechnology Magazine.
Industry
MedTech Dive
As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer experts what encourages and concerns them most about Galleri.
Industry P pharmaphorum
Changing Faces: Board of Director and Advisory Board hires, September 2026 Nicole.Raleigh Mon, 19/10/2026 - 13:00
Industry
Labiotech
Delve into the field of B7-H3 ADCs, a new contender in SCLC cancer as Hansoh Pharma and Medilink bring momentum with positive results. The post B7-H3 ADCs: A new contender in small cell lung cancer and beyond appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu.…
Industry P pharmaphorum
Novavax critic Shah Capital ends its activism campaign Phil.Taylor Mon, 19/10/2026 - 11:36
Industry I In the Pipeline
Here’s one that I wouldn’t have expected. Sulfur is of course an absolutely necessary element for life-as-we-know-it, what with key molecules like cysteine, glutathione, methionine, biotin, taurine, coenzyme A, S-adenosylmethionine, iron-sulfur protein sites and many, many more.…